Oriental Alpha Medical and Health Hybrid Initiation Securities Investment Fund (abbreviation: Oriental Alpha Medical and Health Hybrid Initiation A, code 014841) announced its latest net value on March 21, down 3.26%.
Founded on March 30, 2022, the performance comparison benchmark is the yield of the CSI Medical and Health Index ×60% + the yield of the Hang Seng Healthcare Index ×20% + the yield of the CSI Composite Bond Index ×20%. The fund has returned -8.40% since its inception, 8.40% this year, 0.76% over the past month, and -1.49% over the past year.
The fund manager is Meng Yu. Meng Yu has managed (or intends to manage) the fund since November 29, 2023, with a return of -7.49% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 688050 | Aibo Medical | 7.65% | 110824 | 10.0883 million |
| 600276 | Hengrui Pharmaceutical | 7.04% | 202200 | 9.281 million |
| 688351 | microelectrophysiology | 6.40% | 443049 | 8.4357 million |
| 688617 | Huitai Medical | 6.06% | 21444 | 7.9842 million |
| 688506 | Baili Tianheng | 4.85% | 33308 | 6.3861 |
| 01801 | Innovent Biologics | 4.59% | 178500 | 6.0499 million |
| 688278 | Tebao Biotech | 4.50% | 80765 | 5.9257 million |
| 688266 | Zelgen Pharmaceutical | 3.69% | 77951 | 4.8571 million |
| 002755 | Aosaikang | 3.44% | 357200 | 45409926 |
| Akeso Bio | 3.41% | 80000 | 4.4969 million |
Ticker Name
Percentage Change
Inclusion Date
